Next Safety Announces Stunning Advance in Nicotine Delivery

In a study of 30 test subjects, participants achieved much higher
nicotine blood levels at faster rates than those possible from smoking
cigarettes, without receiving any of the deadly carcinogens. Each
subject inhaled less nicotine than typically inhaled from smoking one
cigarette: with greater psychoactive effects.

According to an article published by the World Health
Organization, cigarettes, which are more addictive than cocaine, will
kill more than 600 million people over the next thirty years.

"Our country is intellectually dishonest, when we allow the
executives from major tobacco companies to live "the country club
lifestyle," while intentionally shipping products that are more
addictive than cocaine, killing millions of people every year; at the
same time, we imprison hundreds of thousands of the poor for selling
marijuana," said C. Eric Hunter, CEO. The nine-year-old son of Mr.
Hunter, poignantly asked a Next Safety colleague, in a discussion of
cigarette addiction, "Why do people kill other people just for money."

Next Safety's revolutionary new device, with advanced dosing
controls, allows those addicted to tobacco a mechanism to receive
nicotine with the same psycho active effects achieved by smoking
cigarettes, without inhaling the known carcinogens contained in
cigarettes. The high degree of control allows the device to be used
for smoking cessation by slowly decreasing inhaled nicotine over long
periods of time or for nicotine replacement, where people are unable
to stop using inhaled nicotine. Additional immediate benefits include
the elimination of second hand smoke and other negative secondary
effects.

In this study smokers achieved mean nicotine venous blood level
increases of 28.4 nanograms per milliliter less than ten seconds after
inhalation. Nonsmokers do not have the same diffusion barrier caused
by the inhalation and subsequent deposition of cigarette combustion
byproducts in the lungs, which smokers have. Therefore, nonsmokers
achieved nicotine blood levels of 129 nanograms per milliliter in less
than ten seconds after inhalation (laboratory analysis performed by
NMS Labs).

This breakthrough in pulmonary drug delivery is not limited to
only nicotine. Any drug soluble in water can now be delivered with
very high efficacy and efficiency utilizing Next Safety's proprietary
pulmonary devices and methods. Treatments enabled by the technology
include the efficient and high efficacy delivery of numerous drugs
never before effectively delivered through pulmonary means. For
example, in the announced nicotine results, more than 74 percent of
the nicotine contained in the device entered the blood stream. Many
drugs currently delivered only through IV or injection in important
classes such as antibiotics, analgesics and anti medics along with
certain vaccinations can now be delivered with very high precision,
efficacy and efficiency.

Next Safety moved into a new 32,000 square ft. facility on July
27th. During the following eighteen months the company expects to
occupy 850,000 square feet of additional office/manufacturing space
and hire approximately 3,600 employees.

Next Safety's nicotine delivery device will be priced at less than
$100.00, with refills costing less than ten percent of the average
pack of cigarettes in developed countries on a nicotine equivalent
basis. The company will begin shipping devices to markets where
current regulations allow in December. Next Safety will ship more than
two million nicotine delivery devices per month during the first
quarter of 2008.

The company will begin sampling devices to certain reporters in
Boston on Wednesday, August 15th, on Thursday, August 16th and in New
York on Monday, August 20th. In addition, the company will hold a
moderated discussion at the Mandarin Oriental in New York on Tuesday,
August 21st. Attendees will include: leading pulmonologists, reporters
and public officials, as well as smokers and non-smokers. For more
information on the August 21st event or for an invitation, please call
or write Christy Cheek at 336.246.7700 ext.230 or
christycheek@nextsafetyinc.com.